The protocol of the EuCARE-hospitalised cohort study was published on 16th of October by EuCARE partners of Workpackages 2, 3 and 5.
This study, which is currently ongoing, follows up hospitalized adult patients with confirmed SARS-CoV-2 infection. The main aim of the study is to gather clinical and laboratory variables from around 35,000 patients. The study started on October 14, 2021 and is scheduled to end on October 13, 2026.
This study will help to reach a better understanding about risk factors for disease severity and the interplay between SARS CoV-2 variants, immune responses and vaccine efficacy.
According to the authors: “The main strengths of this study are the large sample size, the long study duration covering different waves of COVID-19 and the collection of biological samples that will allow future research.”
This study is a clinical trial that has been registered on ClinicalTrials.gov with the unique identifier NCT05463380.
To read the full report go to: https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08658-2